This statistic represents Swiss-based pharmaceutical company Novartis' expenditure on research and development, from 2004 to 2023, as a percentage of revenue. In 2023, research and development expenditure accounted for about one quarter of Novartis' total revenue. The high percentage was driven by the spin-off of Novartis' generics division Sandoz during that year.
Novartis AG's R&D expenditure as a percent of revenue from 2004 to 2023
This statistic was assembled from several editions of Novartis' annual report.
* With the 2015 Annual Report, values back to 2011 were restated, as a result of a series of transactions during 2015.
** Calculated based on given figures.
*** Calculated based on given figures. During this year, eye care division Alcon was spun off and became an own company. Thus, Alcon's revenues and expenses are not included from this year onwards.
**** Calculated based on given figures. During this year, generics division Sandoz was spun off and became an own company, leading to a higher R&D percentage.
Profit from the additional features of your individual account
Currently, you are using a shared account. To use individual functions (e.g., mark statistics as favourites, set
statistic alerts) please log in with your personal account.
If you are an admin, please authenticate by logging in again.
Learn more about how Statista can support your business.
Novartis. (January 31, 2024). Novartis AG's R&D expenditure as a percent of revenue from 2004 to 2023 [Graph]. In Statista. Retrieved November 10, 2024, from https://www-statista-com.ezproxy.canberra.edu.au/statistics/265847/novartis-rundd-expenditure-as-a-percent-of-revenue-since-2004/
Novartis. "Novartis AG's R&D expenditure as a percent of revenue from 2004 to 2023." Chart. January 31, 2024. Statista. Accessed November 10, 2024. https://www-statista-com.ezproxy.canberra.edu.au/statistics/265847/novartis-rundd-expenditure-as-a-percent-of-revenue-since-2004/
Novartis. (2024). Novartis AG's R&D expenditure as a percent of revenue from 2004 to 2023. Statista. Statista Inc.. Accessed: November 10, 2024. https://www-statista-com.ezproxy.canberra.edu.au/statistics/265847/novartis-rundd-expenditure-as-a-percent-of-revenue-since-2004/
Novartis. "Novartis Ag's R&d Expenditure as a Percent of Revenue from 2004 to 2023." Statista, Statista Inc., 31 Jan 2024, https://www-statista-com.ezproxy.canberra.edu.au/statistics/265847/novartis-rundd-expenditure-as-a-percent-of-revenue-since-2004/
Novartis, Novartis AG's R&D expenditure as a percent of revenue from 2004 to 2023 Statista, https://www-statista-com.ezproxy.canberra.edu.au/statistics/265847/novartis-rundd-expenditure-as-a-percent-of-revenue-since-2004/ (last visited November 10, 2024)
Novartis AG's R&D expenditure as a percent of revenue from 2004 to 2023 [Graph], Novartis, January 31, 2024. [Online]. Available: https://www-statista-com.ezproxy.canberra.edu.au/statistics/265847/novartis-rundd-expenditure-as-a-percent-of-revenue-since-2004/
